Evidence map›Paper›PMID 38959256›Full record

ArticlePloS one2024

High prevalence of hepatitis B and HIV among women survivors of sexual violence in South Kivu province, eastern Democratic Republic of Congo.

Parvine Basimane Bisimwa, Giscard Wilfried Koyaweda, Dieudonné Bihehe Masemo, Rodrigue Balthazar Basengere Ayagirwe, Ahadi Bwihangane Birindwa, Patrick Ntagereka Bisimwa, Georges Kikuni Besulani, Théophile Mitima Kashosi, Cadeau Mugisho Matabishi, Bienfait Mitima Misuka and 4 more

Abstract read
In one paragraph

Article in PloS one, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Parvine Basimane BisimwaViral Hepatitis Laboratory, Institut Pasteur de Bangui, Bangui, Central African Republic.
Giscard Wilfried KoyawedaViral Hepatitis Laboratory, Institut Pasteur de Bangui, Bangui, Central African Republic.
Dieudonné Bihehe MasemoFaculty of Medecine, Université Evangélique en Afrique (UEA), Bukavu, Democratic Republic of Congo.
Rodrigue Balthazar Basengere AyagirweMolecular Biology Laboratory, Université Evangélique en Afrique (UEA), Bukavu, Democratic Republic of Congo.
Ahadi Bwihangane BirindwaMolecular Biology Laboratory, Université Evangélique en Afrique (UEA), Bukavu, Democratic Republic of Congo.
Patrick Ntagereka BisimwaMolecular Biology Laboratory, Université Evangélique en Afrique (UEA), Bukavu, Democratic Republic of Congo.
Georges Kikuni BesulaniFaculty of Medecine, Université Evangélique en Afrique (UEA), Bukavu, Democratic Republic of Congo.
Théophile Mitima KashosiFaculty of Medecine, Université Evangélique en Afrique (UEA), Bukavu, Democratic Republic of Congo.
Cadeau Mugisho MatabishiPanzi General Referral Hospital, Internal Medicine, Bukavu, Democratic Republic of Congo.
Bienfait Mitima MisukaFaculty of Medecine, Université Evangélique en Afrique (UEA), Bukavu, Democratic Republic of Congo.
Jean Paulin Mbo MukonkoleFaculty of Medecine, Université Evangélique en Afrique (UEA), Bukavu, Democratic Republic of Congo.
Jean Bisimwa NachegaDepartments of Epidemiology, Infectious Diseases and Microbiology, University of Pittsburgh School of Public Health, Pittsburgh, Pennsylvania, United States of America.
Denis Mukwege MukengereFaculty of Medecine, Université Evangélique en Afrique (UEA), Bukavu, Democratic Republic of Congo.
Narcisse Patrice Joseph KomasViral Hepatitis Laboratory, Institut Pasteur de Bangui, Bangui, Central African Republic.ORCID 0000-0002-4097-7823

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionLimited data are available on the prevalence rates of hepatitis B and acquired immunodeficiency syndrome (AIDS) among women survivors of sexual violence (WSSV) in South Kivu province, in the eastern part of the Democratic Republic of Congo (DRC), where armed conflicts persist. Here, we aimed to assess the prevalence of these two infections in this vulnerable local population.

methodsA total of 1002 WSSV, aged from 18 to 70 years old were enrolled from May 2018 to May 2020 at three healthcare facilities (Panzi, Mulamba and Bulenga hospitals), which are called "The One-Stop Centre Care Model" for the management of sexual violence in South Kivu. Blood samples were collected and tested for hepatitis B virus (HBV) and human immunodeficiency virus (HIV) antigens and antibodies using enzyme-linked immunoassay (ELISA) methods. Subsequently, viral load quantification for HBV and HIV were performed using the GeneXpert. Univariate and multivariate logistic regression models were used to assess factors associated with HIV-positive and HBV-positive status.

resultsFor HBV, overall prevalence was 8.9% (95% CI; 7.2-10.8%), 32.1% (95% CI; 29.3-35.0%), and 14.5% (95% CI; 12.3-16.8%) for HBsAg, anti-HBc and anti-HBs antibodies, respectively. Among the 89 HBsAg-positive patients, 17 (19.1%) were HBeAg-positive. The median age of individuals with a positive HBsAg test was higher than those with a negative test (median: 40 years (IQR 30-52) compared to 36 years (IQR 24-48)). Risk factors for HBV infection were age (≥35 years) (AOR = 1.83 [1.02-3.32]; p = 0.041), having no schooling (AOR = 4.14 [1.35-12.62]; p = 0.012) or only primary school-level (AOR = 4.88 [1.61-14.75]; p = 0.005), and multiple aggressors (AOR = 1.76 [1.09-2.84], p = 0.019). The prevalence of HIV was 4.3% [95% CI: 3.1-5.7%]. HIV/HBV co-infection occurred only in 5 individuals (0.5%). The HBV viral load was detectable (> 1 log10 UI/mL) in 61.8% of HBsAg-positive subjects and 64.8% HIV-positive subjects had a high viral load (≥ 3 log10 copies/mL).

conclusionThis study revealed a high prevalence of HBV and HIV infections among WSSV in South Kivu. The results generated highlight the urgent need for systematic screening of HBV and HIV by integrating fourth-generation ELISA tests in HIV and HBV control programs.

Indexed as

Hepatitis BHIV InfectionsSex OffensesAdolescentAdultAgedDemocratic Republic of the CongoFemaleHepatitis B virusHumansMiddle AgedPrevalenceSurvivorsViral LoadYoung Adult

Identifiers

PMID38959256
PMCPMC11221749

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.